Evaluation of changes in choroidal thickness after implantable collamer lens surgery in high myopia patients with graves’ Ophthalmopathy (inactive phase)

Table 1 Demographic and clinical information

	Group A (GO-high-myopia patients) n = 8	Group B (non-GO-high-myopia patients) n = 18	p-value
Age, y	32.57 ± 4.36	29,25 ± 5.06	0.221
Gender (Female/Male)	5/3	10/8	0.668
Mean time of GD , years	6.20 ± 4.2	0	< 0.001
Preoperative SE, D	−11.84 ± 3.37	−11.21 ± 3.15 D	0.782
1w Postoperatively SE, D	−0.86 ± 0.14 D	− 0.73 ± 0.25 D	0.526
1 m Postoperatively SE, D	− 0.65 ± 0.27 D	−0.60 ± 0.57 D	0.774
3 m Postoperatively SE, D	−0.35 ± 0.27 D	−0.31 ± 0.22 D	0.812
Axial length, mm	27.79 ± 0.42	27.14 ± 1.43	0.898
IOP preoperatively, mmHg	14.35 ± 2.64	15.63 ± 1.36	0.451
IOP 2 h Postoperatively, mmHg	18.65 ± 3.42	18.72 ± 2.32	0.892
IOP 1w Postoperatively, mmHg	15.24 ± 3.11	16.07 ± 2.67	0.243
IOP 1 m Postoperatively, mmHg	15.07 ± 2.62	15.77 ± 2.91	0.455
IOP 3 m Postoperatively, mmHg	14.16 ± 3.12	15.34 ± 2.76	0.767
BCVA preoperatively,	1.42 ± 0.31	1.36 ± 0.37	0.550
BCVA 3 m Postoperatively,	−0.04 ± 0.07	−0.04 ± 0.09	0.998
UCVA 3 m Postoperatively	−0.04 ± 0.11	−0.03 ± 0.12	0.914
Safety index	1.23	1.26	0.858
Efficacy index	1.19	1.21	0.783

Values are expressed as the mean ± standard deviation or n. SE spherical equivalent of refractive error, w week, m month, IOP intraocular pressure, UCVA uncorrected visual acuity (logMAR), BCVA best-corrected visual acuity (logMAR)

ISSN: 1471-2415